Research & Development



  霍光笑著施禮道︰“陛下盡管實驗,但凡是有我雲氏戳記的黃金出現了問題,我雲氏一力承擔。”   無數的大力士日夜兼程向長安跑,唯恐去的晚了會喪失掉平生最好的一次發財契機。大香蕉一本道久在线   “你少吃一點,這是你吃掉的第三個豬蹄了。”雲瑯放下手里的書卷,再也忍不住了。大大香蕉一本道国产   可是,就無鹽詹這個老賊的表現來看,他似乎並不擔心,甚至對金球謊言被戳穿的事情毫不在意。   劉徹大笑道︰“好,這才是我劉氏子孫,待你凱旋,父皇為開庭宴慶功!”尹人在线大香蕉最快   司馬遷並不在意雲瑯的辯解,繼續道︰“陛下的白鹿苑里忽然多了三頭白象,九頭馴化好的灰象,而你雲氏的煉金作坊里濃煙滾滾,一月不息,更不要說今年的秋日里的俸祿發放的極為豐盛,就算是我這個太史令,也分到了兩枚赤金。”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo